CAPELLO, Daniela
 Distribuzione geografica
Continente #
EU - Europa 5.657
NA - Nord America 4.861
AS - Asia 3.214
SA - Sud America 604
AF - Africa 87
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 1
Totale 14.450
Nazione #
US - Stati Uniti d'America 4.765
RU - Federazione Russa 1.438
IE - Irlanda 1.201
SG - Singapore 908
CN - Cina 866
DE - Germania 624
SE - Svezia 605
HK - Hong Kong 590
IT - Italia 547
UA - Ucraina 484
BR - Brasile 456
VN - Vietnam 435
FI - Finlandia 306
FR - Francia 209
IN - India 100
GB - Regno Unito 94
KR - Corea 84
CA - Canada 54
AR - Argentina 47
BE - Belgio 33
ZA - Sudafrica 31
ID - Indonesia 30
NL - Olanda 30
MX - Messico 29
BD - Bangladesh 28
EC - Ecuador 28
IR - Iran 28
JP - Giappone 26
TR - Turchia 26
PL - Polonia 25
EU - Europa 22
IQ - Iraq 19
VE - Venezuela 18
CO - Colombia 17
ES - Italia 17
BJ - Benin 14
AT - Austria 12
PH - Filippine 12
PK - Pakistan 12
PY - Paraguay 12
UZ - Uzbekistan 12
CL - Cile 10
LT - Lituania 10
TN - Tunisia 9
PE - Perù 8
EG - Egitto 7
MA - Marocco 7
CZ - Repubblica Ceca 6
KE - Kenya 6
IL - Israele 5
SA - Arabia Saudita 5
EE - Estonia 4
UY - Uruguay 4
DZ - Algeria 3
KZ - Kazakistan 3
PT - Portogallo 3
RO - Romania 3
TH - Thailandia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BO - Bolivia 2
BW - Botswana 2
GY - Guiana 2
HN - Honduras 2
LB - Libano 2
MY - Malesia 2
NI - Nicaragua 2
OM - Oman 2
PS - Palestinian Territory 2
QA - Qatar 2
SN - Senegal 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AU - Australia 1
BS - Bahamas 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
MN - Mongolia 1
NA - Namibia 1
NG - Nigeria 1
NP - Nepal 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
YE - Yemen 1
ZW - Zimbabwe 1
Totale 14.450
Città #
Dublin 1.201
Jacksonville 878
Hong Kong 588
Dearborn 436
San Jose 386
Singapore 385
Ashburn 309
Wilmington 307
Chandler 291
Beijing 252
Moscow 178
Ho Chi Minh City 157
Lawrence 154
Princeton 153
Lauterbourg 139
San Mateo 136
Los Angeles 108
Andover 103
Ann Arbor 99
Hanoi 87
Buffalo 86
Seoul 82
Novara 69
Boardman 60
Piemonte 59
New York 47
Milan 46
São Paulo 39
Dallas 37
Houston 35
Nanjing 35
Guangzhou 33
Turin 32
Frankfurt am Main 31
Orem 31
Philadelphia 28
Kunming 26
Seattle 26
Chennai 24
Rome 24
Santa Clara 24
Tianjin 24
Tokyo 24
Brussels 23
Hefei 23
Toronto 22
Johannesburg 20
Woodbridge 20
Da Nang 19
Munich 19
Bremen 18
Redondo Beach 18
Rio de Janeiro 18
Denver 17
Hangzhou 17
Norwalk 17
Amsterdam 16
Haiphong 16
Helsinki 16
Jinan 16
Montreal 16
Nuremberg 16
Strasbourg 16
Warsaw 16
Atlanta 15
London 15
Sacramento 15
Savignano Sul Panaro 15
Torino 15
Cotonou 14
Falls Church 14
Shanghai 14
Vercelli 14
Chicago 13
Council Bluffs 13
Jakarta 13
Nanchang 13
Zanjan 13
Boston 12
Brooklyn 12
Mumbai 12
Phoenix 12
Tashkent 12
Ankara 11
Brasília 11
Düsseldorf 11
Guayaquil 11
Hải Dương 11
Manchester 11
Fairfield 10
Mexico City 10
Bologna 9
Fuzhou 9
Grafing 9
Poplar 9
Porto Alegre 9
Stockholm 9
Belo Horizonte 8
Biên Hòa 8
Curitiba 8
Totale 8.068
Nome #
Structure activity relationship studies on Amb639752: toward the identification of a common pharmacophoric structure for DGKα inhibitors 229
Dissecting the Mechanism of Action of Spiperone— A Candidate for Drug Repurposing for Colorectal Cancer 198
Identification of a novel DGKa inhibitor for XLP-1 therapy by virtual screening 189
Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis 174
Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphoma 166
Public Attitude towards Biobanking: An Italian University Survey 163
Psychotropic Drugs Show Anticancer Activity by Disrupting Mitochondrial and Lysosomal Function 152
Alteration of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 146
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas 140
IL LINFOMA PRIMITIVO DELLE SIEROSE E ALTRE MALATTIE LINFOPROLIFERATIVE ASSOCIATE AD HHV-8 136
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 135
Identification of Key Phospholipids That Bind and Activate Atypical PKCs 133
ANALYSIS OF HUMAN HERPESVIRUS TYPE-8 INFECTION IN AIDS-RELATED AND AIDS-UNRELATED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA 131
SIMIAN AIDS-RELATED LYMPHOMA GROWTH IN SCID MICE IS INDEPENDENT OF KARYOTYPIC ABNORMALITIES OR BCL-6 MUTATIONS 130
Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma 128
The diacylglycerol kinase α/atypical PKC/β1 integrin pathway in SDF-1α mammary carcinoma invasiveness. 125
Mutations of CD79A, CD79B and EZH2 genes in immunodeficiency-related non-Hodgkin lymphomas 124
Clinical and molecular features of mucosa-associated lymphoid tissue (MALT) lymphomas of salivary glands 123
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia 122
LINFOMI NON-HODGKIN (NHL) E LINFOMA DI HODGKIN (HD) ASSOCIATI ALL'INFEZIONE DA HIV. CARATTERISTICHE EPIDEMIOLOGICHE, PATOLOGICHE, MOLECOLARI E CLINICHE NELL'ERA DELL'HAART 120
MOLECULAR BASIS OF TARGET THERAPY FOR AGGRESSIVE B-CELL LYMPHOMA 120
AIDS ASSOCIATED LYMPHOMAS ARE EFFICIENTLY LYSED THROUGH COMPLEMENT DEPENDENT CYTOTOXICITY (CDC) AND ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY (ADCC) BY RITUXIMAB 119
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma 117
EXPRESSION OF MUM-1/IRF4 SELECTIVELY CLUSTERS WITH PRIMARY EFFUSION LYMPHOMA AMONG LYMPHOMATOUS EFFUSIONS. IMPLICATIONS FOR DISEASE HISTOGENESIS AND PATHOGENESIS 116
PATTERNS OF CYTOKINE EXPRESSION IN AIDS-RELATED NON-HODGKIN'S LYMPHOMA 116
Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders 116
Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma 116
Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymfoproliferative disorders 116
Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia 114
Clues to the pathogenesis of Waldenström Macroglobulinemia and IgM-MGUS provided by the analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors 114
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21 112
Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma 111
MOLECULAR PATHOPHYSIOLOGY OF INDOLENT LYMPHOMA 110
Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome 109
The prevention of falls in patients with Parkinson's disease with in-home monitoring using a wearable system: a pilot study protocol 108
Simian Virus 40 (SV40) infection in lymphoproliferative disorders: A reappraisal based on five hundred cases 107
AGGIORNAMENTI DI PATOGENESI MOLECOLARE DEI LINFOMI HIV-CORRELATI 103
ANALYSIS OF ABERRANT SOMATIC HYPERMUTATION (SHM) IN NON-HODGKIN LYMPHOMAS OF PATIENTS WITH HCV INFECTION 102
Persistence of neutralizing antibodies to SARS-CoV-2 in first wave infected individuals at ten months post-infection: The UnIRSA cohort study 102
Second-Generation Antipsychotics Induce Metabolic Disruption in Adipose Tissue-Derived Mesenchymal Stem Cells Through an aPKC-Dependent Pathway 100
Characterization of Circulating Vesicles of Complicated and Uncomplicated Systemic Sclerosis Patients and Their Role in Vascular Dysfunction 100
Targeting lysine-specific demethylase 1 (KDM1A/LSD1) impairs colorectal cancer tumorigenesis by affecting cancer cells stemness, motility, and differentiation 100
AP-2 transcription factors in the regulation of ERBB2 gene transcription by oestrogen 100
A case of nodular sclerosis Hodgkin's lymphoma repeatedly relapsing in the context of composite plasma cell-hyaline vascular Castleman's disease: successful response to rituximab and radiotherapy 100
Genomic aberrations affecting the outcome of immunodeficiency-related diffuse large B-cell lymphoma 99
Aberrant somatic hypermutation in tumor cells of nodular lymphocyte-predominant and classical Hodgkin's lymphoma 98
Extracellular vesicles from human plasma for biomarkers discovery: Impact of anticoagulants and isolation techniques 97
DISTRIBUTION AND PATTERN OF BCL-6 MUTATIONS THROUGHOUT THE SPECTRUM OF B-CELL NEOPLASIA 96
POINT MUTATIONS OF THE BCL-6 GENE IN BURKITT's LYMPHOMA 95
ASPETTI MOLECOLARI DEI LINFOMI ASSOCIATI A HIV 95
Evaluating Cryopreservation Methods in Biobanking: Impacts on Biomarker Integrity and Omics Data Reliability 94
THE HOST GENETIC BACKGROUND OF DNA REPAIR MECHANISMS IS AN INDEPENDENT PREDICTOR OF PROGRESSION AND OVERALL SURVIVAL IN DIFFUSE LARGE B-CELL LYMPHOMA 94
CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia 93
Characterization of a novel HHV-8-positive cell line reveals implications for the pathogenesis and cell cycle control of primary effusion lymphoma 93
MOST IMMUNOGLOBULIN HEAVY CHAIN SWITCH MU REARRANGEMENTS IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA ARE INTERNAL DELETIONS 93
EXPRESSION PROFILE OF MUM1/IRF4, BCL-6, AND CD138/SYNDECAN-1 dEFINES NOVEL HISTOGENETIC SUBSETS OF HUMAN IMMUNODEFICIENCY VIRUS-RELATED LYMPHOMAS 92
Uncommon mutation of BAX in AIDS-related non Hodgkin Lymphomas 92
Investigating aging trajectories and determinants in Northern Italy through the Novara cohort study 91
Nuclear Localization of Diacylglycerol Kinase Alpha in K562 Cells Is Involved in Cell Cycle Progression 91
MOLECULAR ANALYSIS OF IMMUNOGLOBULIN VARIABLE GENES IN HIV-RELATED NON HODGKIN LYMPHOMA REVEALS IMPLICATIONS FOR DISEASE PATHOGENESIS AND HISTOGENESIS 91
THE DYNAMIC DNA METHYLOMES OF DOUBLE-STRANDED DNA VIRUSES ASSOCIATED WITH HUMAN CANCER 91
High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia 90
EARLY-STAGE DIFFUSE LARGE B CELL LYMPHOMA OF THE HEAD AND NECK: CLINICO-BIOLOGICAL CHARACTERIZATION AND 18 YEAR FOLLOW-UP OF 488 PATIENTS (IELSG 23 STUDY) 90
UPO Biobank: The Challenge of Integrating Biobanking into the Academic Environment to Support Translational Research 87
MOLECULAR PATHWAYS IN LOW GRADE B-CELL LYMPHOMA 87
Simultaneous diagnosis of CD3+ T-cell large granular lymphocyte leukaemia and true thymic hyperplasia 87
THE MOLECULAR BASIS OF AIDS-RELATED LYMPHOMAGENESIS 86
Molecular history of Richter syndrome: Origin from a cell already present at the time of chronic lymphocytic leukemia diagnosis 86
Downregulation of the major histocompatibility complex class I molecules by human herpesvirus type 8 and impaired natural killer cell activity in primary effusion lymphoma development 86
REARRANGEMENTS OF BCL6, BCL2, c-MYC AND 6q DELETION IN B-DIFFUSE LARGE CELL LYMPHOMA: CLINICAL RELEVANCE IN 71 PATIENTS 85
Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients 85
Prognostic assessment of BCL2-938C>A polymorphism in chronic lymphocytic leukemia 84
Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features 84
Genome wide DNA-profiling of HIV-related B-cell lymphomas 84
GENETIC CHARACTERIZATION OF HHV-8/KSHV POSITIVE PRIMARY EFFUSION LYMPHOMA REVEALS FREQUENT MUTATIONS OF BCL-6: IMPLICATIONS FOR DISEASE PATHOGENESIS AND HISTOGENESIS 83
EPIGENETIC INACTIVATION OF SUPPRESSORS OF CYTOKINE SIGNALLING IN Ph-NEGATIVE CHRONIC MYELOPROLIFERATIVE DISORDERS 83
B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage 83
Hairy cell leukaemia complicated by anti-MAG paraproteinemic demyelinating neuropathy: resolution of neurological syndrome after cladribrine treatment 83
THE MOLECULAR AND PHENOTYPIC PROFILE OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA IDENTIFIES DISTINCT CATEGORIES OF THE DISEASE AND IS CONSISTENT WITH HISTOGENETIC DERIVATION FROM GERMINAL CENTER-RELATED B-CELLS 83
IDENTIFICATION OF THREE DISTINCT SUBGROUPS OF B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA BASED UPON MUTATIONS OF BCL-6 AND IgV GENES 82
CARATTERIZZAZIONE VIROLOGICA E MOLECOLARE DELLE PATOLOGIE LINFOPROLIFERATIVE POST-TRAPIANTO 82
HHV-8/KSHV IS NOT ASSOCIATED WITH AIDS-RELATED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA 82
Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion 82
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes 82
OCCURRENCE OF MULTIPLE MYELOMA AFTER FLUDARABINE TREATMENT OF A CHRONIC LYMPHOCYTIC LEUKEMIA: EVIDENCE OF A BICLONAL DERIVATION AND CLINICAL RESPONSE TO AUTOLOGOUS STEM CELL TRANSPLANTATION 82
Single nucleotide polymorphism-arrays provide new insights in the pathogenesis of post-transplant diffuse large B-cell lymphoma 81
Molecular histogenesis of plasmablastic lymphoma of the oral cavity 81
COMPREHENSIVE CHARACTERIZATION OF IGHV3-21-EXPRESSING B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: AN ITALIAN MULTICENTER STUDY 81
MUTATION OF BAX OCCURS INFREQUENTLY IN AIDS-RELATED NON-HODGKIN'S LYMPHOMAS 81
DETECTION OF BCL-6 REARRANGEMENTS AND p53 MUTATIONS IN MALT-LYMPHOMAS 80
CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH HIGHLY STABLE AND INDOLENT DISEASE SHOW DISTINCTIVE PHENOTYPIC AND GENOTYPIC FEATURES 80
SUBCUTANEOUS “LIPOMA-LIKE” B-CELL LYMPHOMA ASSOCIATED WITH HCV INFECTION: A NEW PRESENTATION OF PRIMARY EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA OF MALT 80
EXPRESSION STATUS OF BCL-6 AND SYNDECAN-1 IDENTIFIES DISTINCT HISTOGENETIC SUBSETS OF HODGKIN'S DISEASE 79
IMMUNODEFICIENCY, INHERITED AND ACQUIRED, AND LYMPHOMAGENESIS 79
Post-transplant lymphoproliferative disorders: role of viral infection, genetic lesions and antigen stimulation in the pathogenesis of the disease 79
DIFFERENTIAL EXPRESSION OF BCL-6, CD138/SYNDECAN-1 AND EBV-ENCODED LATENT MEMBRANE PROTEIN-1 IDENTIFIES DISTINCT HISTOGENETIC PATHWAYS OF AIDS-RELATED NON-HODGKIN's LYMPHOMAS 78
IMMUNOGLOBULIN REGION GENE USE AND STRUCTURE SUGGEST ANTIGEN SELECTION IN AIDS-RELATED PRIMARY EFFUSION LYMPHOMAS 78
Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas 78
HUMAN HERPESVIRUS TYPE-8 (HHV-8) IN HAEMATOPOIETIC NEOPLASIA 77
JAK2 V617F mutation in leukaemic transformation of philadelphia-negative chronic myeloproliferative disorders 76
Totale 10.403
Categoria #
all - tutte 70.177
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.177


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021219 0 0 0 0 0 0 0 0 0 16 174 29
2021/20221.182 23 4 210 148 85 18 114 26 75 22 231 226
2022/20232.254 183 93 112 87 130 194 57 96 1.196 8 65 33
2023/2024823 43 33 61 19 124 48 229 49 3 10 67 137
2024/20251.607 21 20 23 45 51 222 124 103 437 166 52 343
2025/20265.142 208 191 467 844 393 394 827 990 472 356 0 0
Totale 14.547